Ascend Wellness Holdings (AAWH) Other financing activities (2021 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Other financing activities came in at $27000.0 in Q1 2026, down 66.25% quarter-over-quarter from $80000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Other financing activities (2021 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other financing activities history runs 5 years deep, the most recent figure standing at $27000.0 for Q1 2026.
- On a quarterly basis, Other financing activities changed N/A year-over-year to $27000.0 in Q1 2026; TTM through Mar 2026 was $167000.0, a 115.9% increase from a year earlier, with the FY2025 full-year figure at $140000.0, changed N/A from the prior year.
- Other financing activities eased to $27000.0 in Q1 2026 per AAWH's latest filing, from $80000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $7.0 million in Q3 2023 and bottomed at -$7.0 million in Q4 2023.
- The 4-year median for Other financing activities is $60000.0 (2025), against an average of $23857.1.
- Across the five-year window, Other financing activities surged 85.0% in 2024 and soared 107.62% in 2025, its largest moves.
- Year by year, Other financing activities stood at -$7.0 million in 2023, then jumped by 85.0% to -$1.0 million in 2024, then soared by 107.62% to $80000.0 in 2025, then sank by 66.25% to $27000.0 in 2026.
- Per Business Quant, the three latest AAWH Other financing activities figures stand at $27000.0 (Q1 2026), $80000.0 (Q4 2025), and $60000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27,000.00 |
| Mar 31, 2026 | 27,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Dec 31, 2024 | -1.05 Mn |
| Dec 31, 2024 | -1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Dec 31, 2023 | -7.00 Mn |
| Dec 31, 2023 | -7.00 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Sep 30, 2023 | 7.00 Mn |
| Dec 31, 2021 | -86.07 Mn |
| Dec 31, 2021 | -86.07 Mn |